Explore how therapeutic peptides offer new hope in combating H. pylori-induced gastric cancer, addressing antibiotic resistance with innovative targeted therapies.
Exploring the connection between H. pylori infection, hs-CRP levels, and gastric cancer risk through CagA virulence factor
New research reveals how H. pylori eradication affects ghrelin levels and long-term metabolic health, with implications for cancer risk monitoring.